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Abstract 
Background:  After artemisinin resistance was reported, the Myanmar artemisinin resistance containment (MARC) 
project was initiated in 2011. One of the activities of MARC is to train volunteers for early diagnosis and prompt treat-
ment by providing rapid diagnostic tests (RDT) and artemisinin combination therapy. This study aimed to fulfil the 
gap of information on the challenges faced by malaria volunteers in artemisinin-containment areas.
Methods: A cross-sectional, descriptive study was conducted in 11 townships in MARC areas to assess the challenges 
in early diagnosis of malaria and treatment by malaria volunteers using qualitative and quantitative approaches.
Results: Altogether 405 volunteers participated in the study. Although 97.5 % of volunteers can interpret a positive 
result for malaria, only 41.2 % correctly stated the persistence of a positive result in recently infected cases. Over 80 % 
knew the effects of temperature and humidity on performance of the malaria RDT. Unexpectedly, 15.1 % perceived 
that expired RDTs can still be useful for diagnosis although 98.3 % of respondents cited that the overall results of RDTs 
were reliable. Although most of them knew the treatment for malaria based on RDT results, some could not give the 
correct answer, while a few (2 %) mentioned artesunate monotherapy for RDT-negative cases. Training received by 
volunteers was also varied in study sites and 92.1 % believed that it was not sufficient. A certain portion of them faced 
the problem of regular supply of RDTs (9.9 %) and drugs (47.5 %), interpretation of result of RDTs (30 %), and perform-
ing blood test (20 %). The median RDT tested per month (25th, 75th percentile) was 6.0 (2.0, 15.0) indicating the need 
for prioritization based on endemicity. Regular reporting, supervision, monitoring system, and proper refresher train-
ing using uniform content of guideline to correct misconception of the volunteers, were needed to be strengthened. 
Moreover, the reliable and regular supply of materials and exchange system for expired RDTs and anti-malarials was 
important in the effectiveness of volunteers in MARC zones.
Conclusions: Adequate refresher training, monitoring, supervision, and regular reliable supply of RDTs and anti-
malarials were needed for capacity strengthening of volunteers in MARC zones.
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Background
Artemisinin-based combination therapy (ACT) is the first-
line treatment for uncomplicated falciparum malaria in 
most endemic countries. Recent evidence of artemisinin-
resistant Plasmodium falciparum in the Cambodia-
Thailand border stimulated the launch of a multifaceted 
containment programme. This programme covered early 
diagnosis and appropriate treatment, decreasing drug 
pressure, optimizing vector control, targeting the mobile 
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population, strengthening management and surveillance 
systems, and operational research [1].
Malaria-endemic countries should consider the follow-
ing classification for implementation. This classification 
elucidates Tier I areas with credible evidence of arte-
misinin resistance, Tier II areas with significant inflows 
of people from Tier I areas, including those immediately 
bordering Tier I and III areas with no evidence of arte-
misinin resistance and limited contact with Tier I areas 
[2, 3].
In Myanmar, rapid diagnosis tests (RDTs) have been 
used for diagnosis of malaria in areas where there is no 
reliable microscopic facility, since the year 2000. Plasmo-
dium falciparum is the main pathogen for malaria (75 %), 
followed by vivax infection (25  %); 152,195 cases have 
been reported in 2013 [4]. Combo RDT that can detect 
the PfHRP2 and pan-pLDH or vivax-specific pLDH 
devices have been distributed [5]. The implementation 
of RDTs commenced in 2003 in rural health centres and 
sub-centres in 284 endemic townships. About 400,000–
500,000 tests have distributed annually, since 2006 [5]. 
A total of 887,969 and 1,587,745 fever cases were tested 
by RDT in 2012 and 2013, respectively. Local health vol-
unteers are the major human resources for diagnosis 
of malaria using RDTs in containment areas [5]. How-
ever, challenges, including problems of distribution for 
widespread adoption of diagnostics by RDTs, have been 
reported in many other countries [6] as has variability in 
the quality and performance of RDTs, including sensitiv-
ity, specificity, heat stability, and longevity [7, 8]. Further-
more, evidence from other studies [9, 10] suggests that 
some providers and patients are unaware of the harm 
associated with treating cases without malaria with ACT, 
and in some settings, patients with negative results from 
a diagnostic test still receive and take anti-malarial medi-
cine. This presumptive use of ACT may lead to unnec-
essary drug pressure and subsequently emergence and 
spread of drug resistance [11]. Moreover, over-usage of 
ACT causes unnecessary cost of anti-malarials and fail-
ure to treat other serious causes of fever [12].
In Tanzania, proper provider training and regular 
supervision encouraged compliance with testing results. 
In Ghana, in health facilities without previous access to 
malaria diagnostic testing, the introduction of RDTs sig-
nificantly reduced the over-prescription of anti-malari-
als [13]. Nevertheless, ensuring the use of RDTs for the 
diagnosis of malaria and compliance with the results in 
the informal private sector is likely to be one of the chal-
lenges [3]. One study in Kenya [14] noted the demand 
for RDTs in the private sector at low prices, but access 
to RDTs only modestly improved targeting of ACT. The 
underlying reason was that most patients with negative 
test results purchased ACT anyway. Therefore, exploring 
the hidden problems and challenges in utilization of 
RDTs for diagnosis of malaria is essential for implemen-
tation of artemisinin containment measures.
In Myanmar, artemisinin resistance containment 
(MARC) areas trained local health volunteers to diagnose 
malaria by using RDTs and to provide ACT treatment 
[15]. Efforts are underway to improve the compliance of 
both providers and patients to the results of testing. The 
fifth objective of MARC is “to strengthen surveillance 
and operational research for development of evidence-
based policies and strategies and for decision-making”. To 
fulfil this goal, there is a need to explore the challenges in 
diagnosis of malaria by RDT and treatment by using ACT 
among local health volunteers in MARC zones. There 
are potential links between the knowledge component of 
volunteers, including training sessions, refresher courses, 
attitudes, and perceptions and their practices related to 
RDTs, such as supply and support system, supervision, 
reporting and feed-back, and the effective utilization of 
RDTs and ACT by volunteers; this is the first study to ful-
fil the gap of knowledge after implementation of the vol-
unteer programme in MARC zones.
Methods
Study design
A field-based, cross-sectional, analytical study with com-
bined quantitative and qualitative approaches was con-
ducted to assess the challenges encountered by malaria 
volunteers in MARC zones. The objectives of this study 
were to: identify the status of the utilization of RDTs in 
diagnosis of malaria by local health volunteers in MARC 
zones; to find out the knowledge, attitude and practices 
of health workers related to use of RDTs; to find out the 
barriers and constraints in diagnosis of malaria using 
RDTs and prescription of anti-malarials by malaria vol-
unteers in field conditions.
Study area and study population
This study was carried out in 11 townships, (five selected 
townships each from Tier I areas of MARC zones) that 
includes Tanintharyi Region, Mon State and Bago East 
Region (Fig. 1). The vector-borne disease control (VBDC) 
teams trained local health volunteers in these areas for 
early diagnosis of malaria by using RDTs and treatment 
by ACT. The number of local health volunteers varied 
in different regions depending upon the population and 
logistic parameters.
Sampling procedure and sample size
In Myanmar, State or Regional Health Departments 
are composed of Township Health Departments that 
have rural health centres [5]. To get the representa-
tiveness for involvement of volunteers, a multistage, 
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stratified, cluster-sampling technique was used. Five out 
of all townships in each State or Region of MARC Tier 
I were randomly selected for the study. If the number of 
townships was fewer than five, all the townships were 
included. The health centres of a selected township were 
listed and five health centres were randomly selected. If 
there were no more than five, all of the health centres 
were selected for the study. All local health volunteers 
under the jurisdiction of each selected health centre were 
recruited.
Data collection methods
Trained interviewers used the pre-tested and modified 
structured interview questionnaires (SIQ) for face-to-
face interviews of trained local health volunteers. The 
SIQ was designed to collect information on knowledge, 
attitude, perceptions, practices, barriers, and challenges 
on early diagnosis and treatment of malaria in MARC 
areas. For focus group discussion (FGD), six to eight 
trained local health volunteers were invited from three 
study sites in each township. Discussion guidelines com-
prised open-ended questions focusing on experiences of 
malaria diagnosis by RDTs, knowledge on treatment of 
malaria by ACT, feasibility in the study areas especially 
highlighting the importance of RDT use, and favourable 
and unfavourable conditions during implementation. 
The face-to-face interviews were conducted in volun-
teers’ homes in field sites using local language, and train-
ing materials, records of results and storage of RDTs and 
antimalarials were also requested.
Key informant interviews (KIIs) were carried out 
by using pre-tested guidelines for post-intervention 
assessment in MARC zones. Key informants included 
Regional Officers of VBDC teams of the study sites, all 
township Medical Officers from selected townships to 
explore the challenges encountered by malaria volun-
teers concerning their training, reporting, supervision, 
and monitoring.
Data processing and analysis
Data collected during the survey were checked and 
entered into computer using Microsoft EXCEL and Epi 
Info version 7. The analysis was performed by SPSS ver-
sion 20. Qualitative data were transcribed and analysed 
across themes and sub-themes for triangulation with 
quantitative data for meaningful interpretations.
Ethical considerations
All respondents were clearly informed on the nature and 
the purpose of the study, private questions and benefits, 
right to refuse to participate or to withdraw from the 
study, and confidential handling of the data. Participa-
tion in this project was entirely voluntary. This project 
obtained ethical clearance from the Ethical Review Com-




In this study, a total of 405 volunteers were invited and 
all actively participated after giving informed con-
sent. Among them, 42.9 % (172/405) of volunteers were 
trained by VBDC and 57.1  % (231/174) by non-govern-
mental organizations (NGOs) that included Population 
Services International (PSI): 88 volunteers, World Vision 
Myanmar (WVM): 42 volunteers, International Organi-
zation for Migration (IOM): 42 volunteers, and Myanmar 
Health Assistant Association (MHAA): 46 volunteers. 
Around 3.2 % (13/405) of volunteers mentioned that they 
were trained by more than one organization. The MHAA 
alone was responsible for malaria volunteers in Shweg-
yin Township, Bago Region. The number of participants 
from different townships is shown in Fig. 2. Most of them 
(350/405, 86.5 %) were from the private sector (farmers, 
fishermen, manual workers, etc.). Only 13.5 % (55/405) of 
volunteers were government staff, such as teachers, offic-
ers, etc. Around 70 % (282/405) attained middle and high 
school level and only 10.4  % (42/405) primary school 
level.
Fig. 1 Study sites. Light red areas represent MARC zone I. Light yellow 
areas represent MARC zone II. Study townships are shown as blue 
triangles
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Knowledge on malaria RDT
Almost all respondents (99.5 %) knew that RDT is a blood 
test for malaria. Interestingly, (173/405, 42.7  %) could 
not mention the brand name of RDT that can detect the 
HRP2 alone or combination with pan-pLDH or vivax-
specific pLDH, such as PARACHECK (191/405, 47.2 %), 
SD (130/405, 32.1  %), CARE START (120/405, 29.6  %), 
OPTIMAL (23/405, 5.7  %), and VESITEST (14/405, 
3.5 %). Although most (395/405, 97.5 %) can interpret the 
positive result of RDT to indicate malaria infection and 
315/405, 77.7 % noticed that partially treated cases may 
be positive result of RDT, only 167/405, 41.2 % knew that 
persistence of HRP2 can cause a positive result of RDT 
after treatment.
Regarding treatment of falciparum malaria, 46.9  % 
(190/405) answered ‘one of ACT for treatment’, another 
43.2  % (175/405) mentioned ‘ACT followed by pri-
maquine’, and only 7.2  % (29/405) did not remember 
the treatment. On treatment for vivax, mostly (85.4  %, 
346/405) answered correctly the recommended treat-
ment: chloroquine followed by primaquine. Unex-
pectedly, a few (8/405, 2  %) answered that artesunate 
monotherapy could be given for RDT-negative cases. 
Their responses for treatment of malaria based on the 
result of RDT are shown in Fig. 3.
As might be expected, training was the main source of 
information on the knowledge of RDT (388/405, 95.8 %), 
health staff (122/405, 30.1 %), and manuals and instruc-
tions (81/405, 20 %).
More than 80  % of respondents knew that tempera-
ture and humidity could affect the performance of RDTs. 
However, 15.1  % (61/405) mentioned that expired RDT 
can be useful for diagnosis. Most of them could inter-
pret the positive result for diagnosis of malaria (395/405, 
97.5  %). However, some (167/405, 41.23  %) mentioned 
that recently treated cases could provoke positive results. 
In addition, more than half of the respondents cited 
that past infection of malaria could be detected by RDT 
(Table 1).
Attitudes towards the result of malaria RDT
Around 98  % felt that the results of malaria RDT were 
reliable. If the result was doubtful by volunteers (faint 
band, no control band, suspected fever cases with neg-
ative RDT result, etc.), 48  % would like to test another 
brand of RDT. Conversely, 47  % would like to refer 
immediately. Nearly 90 % mentioned that blood test for 
malaria could be done only after training. If they wanted 
to know more information, 95.5 % referred to their sen-
iors and 60  % wanted to search the literature. Nearly 
100  % understood that they should adhere to guide-
lines for blood testing and prescription of anti-malar-
ials. Moreover, 92  % would like to refer immediately if 
a patient’s conditions worsened. Very few (6 %) wanted 
to wait and only 1.7  % wanted to change the drugs by 
themselves.
Fig. 2 Number of participants from 11 townships in Tier I areas of 
MARC zone
Fig. 3 Knowledge on treatment of malaria based on RDT result by 
malaria volunteers
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Practices related to RDT
One-third of participating volunteers performed one 
to five blood tests per month. Nearly 15  % received no 
patients for blood testing. The median RDT tested per 
month (25th, 75th percentile) was 6.0 (2.0, 15.0) and pos-
itive RDT per month was 1 (0.0, 4.0) volunteers in previ-
ous month. Among them 16/405 (14.8 %) had conducted 
no blood tests in the past month while three volunteers 
tested up to 100 RDTs; exceptionally, one volunteer 
performed up to 200 RDTs. Unexpectedly, around 19 % 
experienced invalid results (no control band) and 23  % 
had encountered suspect results of RDT (faint band, 
unclear band, and fever with chills and rigours with nega-
tive RDT result). The number of volunteers who received 
training varied widely. Approximately 70.1  % of them 
received training at least one to two times. Around 92 % 
felt that the training provided was not sufficient for them. 
Nearly 10  % faced problems on regular supply of RDTs 
and drugs (47.5  %), interpretation of results of RDTs 
(30 %), and performing the blood test (20 %).
Reporting and supervision
Around 91  % (369/405) of respondents sent their 
monthly reports regularly to the responsible 
organization. Of them, those who were trained by 
VBDC teams attained the highest rate (158/172, 91.9 %). 
There were variations in supervision and monitoring of 
volunteers by different organizations. The VBDC teams 
supervised and monitored 53  % (91/174) of volun-
teers but WVM monitored nearly 60  % (25/42) of vol-
unteers. The IOM and PSI attained much higher rates 
(35/42, 83 % vs 80/88, 91 %). The rate of monitoring and 
supervision of volunteers by HAA was 100  %. Among 
the volunteers trained by more than one organization, 
nearly 62 % (8/13) received supervision and monitoring 
(Fig. 4).
Qualitative findings
Excerpts from KIIs revealed the perceptions, opin-
ions and challenges in volunteer training programmes 
and their use of RDTs and ACT. One of the VBDC staff 
expressed his opinion on training of volunteers:
Volunteer projects should be prioritized. More effort 
is necessary in endemic and really hard-to-reach 
areas than easily accessible areas.
One township Medical Officer (TMO) expressed his 
views on the training programme:
The training content and duration are not uniform 
for volunteers. It should be standardized across each 
and every organization involved. The training con-
tents should be prioritized as nice to know, must 
know etc. and the level of understanding of trainers 
is also important.
Apart from the training, one volunteer highlighted the 
inadequate supply of materials compared to demand:
When I requested malaria RDT, about 20 tests per 
month were provided. It was not sufficient enough 
when I needed to handle more than 30 patients. In 
that case, I borrowed RDTs from others.
One volunteer shared his experience that he had not 
come across RDT-positive patients:
Table 1 Knowledge and  attitude of  trained volunteers 
on interpretation of malaria RDTs
a Column percentages do not add up to 100 due to single item responses
b Past infection means history of malaria infection in patients that is not recently 
(>3 months)
Result Interpretationa Frequency Percent
Positive result Malaria infection 395 97.53
Recently treated cases 167 41.23
Partially treated cases 315 77.78
Negative result No malaria 388 95.80
Past infectionb 167 41.23
Improper testing 224 55.31
Expired or poor storage 
of RDT
273 67.41
Invalid result Device error 353 87.16
Operational error 185 45.68
Source of information Training 388 95.80
Health staff 122 30.12
Books and instructions 
(manual)
81 20.00
Medical sale personnel 3 0.74
RDT result is reliable Yes 398 98.27
No 7 1.73
If the RDT result is  
doubtful
Refer to health centres 191 47.16
Try with another one 
more
195 48.15
Try with another brand 
test
19 4.69
Fig. 4 The status of supervision and monitoring of volunteers trained 
by different organizations
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I wanted to see the positive result but not yet encoun-
tered. So, I had to avoid the provision of drugs to 
patients and just referred them to midwives.
One volunteer shared his usual practice:
When performing malaria RDTs, if the control line 
appears, it is still in good condition even after the 
expiry date.
Volunteers shared their experiences on challenges 
encountered in supplies of RDT and ACT and their ideas 
on improvement to the training programme:
Training should include short field trip to the village 
to practice with real patients.
One TMO complained about the reporting:
We request to send the report regularly but some 
volunteers do not send monthly.
One volunteer explained failure to send the monthly 
report regularly:
It is not easy to report monthly because sometimes, 
we did no blood test per month, difficulties in trans-
portation, high cost for transportation to send the 
report, and no time to send the report.
Concerning supervision and monitoring, one VDBC 
staff shared his experience:
We know to perform the supervision and monitor-
ing. But there is no specific budget allocation. So, we 
have to do together with other health activities.
Discussion
There are reports of effectiveness of volunteers in control 
of communicable diseases [16, 17]. Conversely, one study 
mentioned that they did not adhere to their treatment 
plans in line with results of RDTs [9]. Another study from 
Sudan found that community volunteers prescribed ACT 
in 30 % of fever cases with negative RDT results [16]. The 
misdiagnosis of malaria can lead to severe disease and 
death, or unnecessary exposure to anti-malarial drugs, 
which may lead to drug toxicity and resistance and, in 
turn, lack of confidence in health care services [18].
In this study, although most can interpret an RDT 
result correctly, only 41 % of respondents were aware that 
‘recently treated cases’ is one of the possible reasons for 
positive result, while about 55 % noticed that ‘improper 
testing’ may cause a negative result. Although pan-pLDH 
antigen band disappeared after treatment, persistence of 
the HRP2 antigen in recently treated patients was com-
mon [19] and may lead to misinterpretation of an RDT 
result. This means that the volunteer’s knowledge on the 
interpretation of the RDT result needed to be improved, 
especially on recurrent fever cases who had been diag-
nosed and treated for malaria recently.
In the present study, the overall knowledge of RDT by 
malaria volunteers was satisfactory, but misconceptions 
existed. Around 15 % of the respondents mentioned that 
expired RDTs could be useful for diagnosis of malaria and 
were not aware of the effect of temperature and humid-
ity on malaria RDTs. Similar findings have been reported 
in one study [20] that observed only 9 % of participants 
checked the expiry date of RDTs and 24  % were unable 
to read the test correctly. In the present study, almost all 
respondents mentioned that the results of RDTs were 
reliable. If the result of a RDT was doubtful, 48 % wanted 
to test another one and another 47 % wanted to refer to 
hospital or other laboratory. A small portion (6 %) men-
tioned that they wanted to wait and see if the patient’s 
condition worsened. Although the general attitude of 
malaria volunteers towards the use of RDT and ACT was 
satisfactory, doubtful RDT results highlight the need for 
guidelines for suspect RDT results.
Nearly half of participants knew Coartem (ACT) for 
treatment of P. falciparum mono-infection. Only 43.2 % 
correctly mentioned a single dose of primaquine should 
be followed after ACT for P. falciparum mono-infection. 
Although only 2  % mentioned artesunate monotherapy 
for RDT-negative cases, it reflected the self-treatment of 
artesunate monotherapy in endemic areas. Their miscon-
ceptions required attention for arrangements of further 
refresher training.
This study found that 19  % of volunteers experienced 
invalid RDT results and 23 % had encountered suspected 
results of RDT, such as faint band, unclear band, and 
fever with chills and rigours with negative RDT results. 
This finding indicates the need for guidelines and instruc-
tions to volunteers on how to proceed with invalid or 
doubtful RDT results in the management of cases. More-
over, 30 % had the problem of interpretation of a result, 
such as invalid or confused on interpretation of the result 
of RDT. Repetitively negative results of an RDT was also 
reported in the qualitative findings and led to doubt in 
the quality and interpretation of the blood test, causing 
attrition in the volunteer.
The workload for performing the malaria RDT widely 
varied among volunteers. The median RDT tested per 
month (25th, 75th percentile) was 6.0 (2.0, 15.0). While 
few were performing more than 50–100 tests per month, 
some had no patients for blood testing or all nega-
tive results. This may be due to equal assignment of the 
volunteers regardless of the prevalence of the disease 
in different endemicity and local transmission. Prior-
ity assessment of the villages should be done based on 
accessibility to a health care centre, endemicity, malaria 
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micro-stratification, and transportation. Villages close 
to health facilities should be omitted for volunteer train-
ing and unnecessary training of volunteers in irrelevant 
villages should be brought to a halt to avoid wastage of 
human resources, RDT and drugs. Some showed lack of 
knowledge for RDT-negative cases. Early referral systems 
should be encouraged in RDT-negative cases.
In this study, some experienced difficulties requesting 
materials. The reliable and regular supply of RDT and 
anti-malarials was important in implementation of the 
volunteer project. Although most of the volunteers sent 
their monthly reports regularly, many factors influencing 
regular reporting have been explored, such as no blood 
test per month, difficulties in transportation, high cost for 
transportation to send the report, and no adequate time 
to send the report. Supervision was still weak, especially 
for VBDC-trained volunteers. However, Myanmar HAA 
and PSI had highest supervision rates for their volunteers. 
Their staff collected the monthly reports and performed 
the supervision and monitoring in the villages where vol-
unteers resided. Conversely, there was no specific budget 
allocation for supervision and monitoring, precluding 
long-term, regular supervision and monitoring of volun-
teers. The supervision component was to be strengthened 
for quality control and sustainability of the programme as 
also stated by one cluster, randomized, controlled study 
on volunteers in Bago Region, Myanmar [17].
Conclusions
In Tier I areas of MARC zones, local health volunteers 
can carry out early diagnosis and prompt treatment of 
malaria effectively in remote sites. However, there were 
wide variations in the workload of volunteers concerned 
with confirmation of malaria by RDT. Prioritization of 
supplies of RDTs is required to be consistent with the 
prevalence of malaria in the locality. Furthermore, the 
reliable and regular supply of RDTs and anti-malarials is 
important for malaria control in remote sites. There are 
gaps in knowledge and misconception of volunteers that 
might hamper their performance in using RDTs for diag-
nosis of malaria and adequate treatment with ACT.
Policy implications and recommendations
  • The knowledge of the malaria volunteers on early 
diagnosis and prompt treatment of malaria needs 
improvement by proper refresher courses that should 
be uniform for all organizations involved in volunteer 
training and should correct common misconceptions 
of volunteers.
  • Some volunteers needed more RDTs and anti-malar-
ials, while some received more than enough. Priority 
assessment is essential for equity in supply of malaria 
RDTs and ACT.
  • Regular and reliable supply of malaria RDTs and ACT, 
including the exchange system for expired tests.
  • Weaknesses in supervision by the responsible 
authority, especially for volunteers trained by VBDC, 
can be alleviated through proper refresher training, 
monitoring and supervision in order to enhance per-
formance.
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